What is ParaTechs?
ParaTechs Corporation is a biotechnology firm dedicated to advancing research in assisted reproductive technology and protein expression through innovative technologies and products. The company offers a range of solutions, including devices for non-surgical embryo transfer, artificial insemination, and embryo vitrification, alongside a nitrate reductor kit. Established in 2004 and built on intellectual property from the University of Kentucky, ParaTechs focuses on providing cost-effective tools for researchers and actively seeks commercial licensing and collaborative research partnerships.
How much funding has ParaTechs raised?
ParaTechs has raised a total of $55K across 1 funding round:
Debt
$55K
Debt (2021): $55K with participation from PPP
What's next for ParaTechs?
With the recent substantial expansion capital, ParaTechs is poised for significant growth and scaling of its operations. The company's strategic focus on developing innovative biotechnologies for assisted reproduction and protein expression research, coupled with its open approach to collaborations and licensing, suggests a trajectory aimed at solidifying its market position and potentially expanding its product pipeline. This investment will likely fuel further research and development, enhance manufacturing capabilities, and broaden market reach, positioning ParaTechs as a key player in its specialized biotech niches.
See full ParaTechs company page
